Favipiravir: A new and emerging antiviral option in COVID-19

U Agrawal, R Raju, ZF Udwadia - Medical Journal Armed Forces India, 2020 - Elsevier
With over 16 million cases reported from across the globe, the SARS-CoV-2, a mere 125
microns in diameter, has left an indelible impact on our world. With the paucity of new drugs …

[HTML][HTML] A review of the safety of favipiravir–a potential treatment in the COVID-19 pandemic?

V Pilkington, T Pepperrell, A Hill - Journal of virus eradication, 2020 - Elsevier
Background Repurposing broad-spectrum antivirals is an immediate treatment opportunity
for 2019 coronavirus disease (COVID-19). Favipiravir is an antiviral previously indicated for …

[HTML][HTML] Ebola virus disease: An emerging and re-emerging viral threat

M Rojas, DM Monsalve, Y Pacheco… - Journal of …, 2020 - Elsevier
The genus Ebolavirus from the family Filoviridae is composed of five species including
Sudan ebolavirus, Reston ebolavirus, Bundibugyo ebolavirus, Taï Forest ebolavirus, and …

[HTML][HTML] Marburg virus disease: a summary for clinicians

MG Kortepeter, K Dierberg, ES Shenoy… - International Journal of …, 2020 - Elsevier
Objectives This article summarizes the countermeasures for Marburg virus disease, focusing
on pathogenesis, clinical features and diagnostics. There is an emphasis on therapies and …

[HTML][HTML] Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir

PA Negru, AF Radu, CM Vesa, T Behl… - Biomedicine & …, 2022 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) represents an unmet clinical need, due to a
high mortality rate, rapid mutation rate in the virus, increased chances of reinfection, lack of …

Antiviral potential of natural resources against influenza virus infections

J Eichberg, E Maiworm, M Oberpaul, V Czudai-Matwich… - Viruses, 2022 - mdpi.com
Influenza is a severe contagious disease caused by influenza A and B viruses. The WHO
estimates that annual outbreaks lead to 3–5 million severe infections of which approximately …

Development and validation of a method for quantification of favipiravir as COVID-19 management in spiked human plasma

M Hailat, I Al-Ani, M Hamad, Z Zakareia, W Abu Dayyih - Molecules, 2021 - mdpi.com
In the current work, a simple, economical, accurate, and precise HPLC method with UV
detection was developed to quantify Favipiravir (FVIR) in spiked human plasma using …

Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019

M Louchet, J Sibiude, G Peytavin, O Picone… - American journal of …, 2020 - Elsevier
Objective Treatment of coronavirus disease 2019 is mostly symptomatic, but a wide range of
medications are under investigation against severe acute respiratory syndrome coronavirus …

Reemergence of Marburgvirus disease: update on current control and prevention measures and review of the literature

R Elsheikh, AM Makram, H Selim… - Reviews in Medical …, 2023 - Wiley Online Library
In 1967, the very first case of the Marburgvirus disease (MVD) was detected in Germany and
Serbia sequentially. Since then, MVD has been considered one of the most serious and …

The number of cases, mortality and treatments of viral hemorrhagic fevers: A systematic review

D Belhadi, M El Baied, G Mulier, D Malvy… - PLOS Neglected …, 2022 - journals.plos.org
Background Viral hemorrhagic fevers (VHFs) are a group of diseases, which can be endemo-
epidemic in some areas of the world. Most of them are characterized by outbreaks, which …